A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells
Sofía Grille, Andreína Brugnini, Martha Nese, Esteban Corley, Frank W. Falkenberg, Daniela Lens, José A. ChabalgoityVolume:
59
Language:
english
Pages:
9
DOI:
10.1007/s00262-009-0768-6
Date:
April, 2010
File:
PDF, 431 KB
english, 2010